Healthy high growth potential

Results

1508

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1508 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
2368
NT$901.00-2.8%167.0%NT$455.3bNT$1,576.8840.238.2%1.1%Tech
7685
JP¥3,145.00-7.5%126.9%JP¥194.4bJP¥4,666.6726.425.5%0.7%Retail
A458870
₩27,350.00-9.0%137.5%₩1.0t₩69,000.0034.241.5%n/aHealthcare
FWRY
ج.م18.92-1.4%45.0%ج.م64.5bج.م22.4524.227.3%n/aDiversified Financials
7769
NT$6,055.00-0.2%285.7%NT$1.1tNT$9,358.0075.644.6%1.1%Semiconductors
6223
NT$5,705.001.9%464.9%NT$559.0bNT$8,207.27151.958.3%0.4%Semiconductors
KEBNI B
SEK 1.04-4.3%-60.1%SEK 285.3mSEK 1.252.590.9%n/aTech
9218
JP¥740.000%10.1%JP¥7.8bn/a32.728.9%1.4%Healthcare
456A
JP¥1,390.00-6.9%n/aJP¥127.4bn/a39.323.4%n/aRetail
CORT
US$95.364.1%37.9%US$10.2bUS$106.00219.347.8%n/aPharmaceuticals & Biotech
MDGL
US$544.511.6%85.1%US$12.6bUS$679.6411.159.7%n/aPharmaceuticals & Biotech
LPK
€13.75-7.4%65.1%€336.3m€19.003.4116.4%0%Tech
LITE
US$762.99-0.3%611.9%US$59.4bUS$1,104.89135.256.5%n/aTech
AGP
€6.96-1.7%-8.4%€126.9m€8.5725.539.1%n/aCapital Goods
CRDO
US$213.150.5%97.5%US$39.7bUS$279.2984.227.7%n/aSemiconductors
AXSM
US$241.008.7%140.1%US$12.4bUS$282.5117.557.0%n/aPharmaceuticals & Biotech
CDR
zł226.20-1.8%-9.4%zł22.6bzł235.1343.830.7%0.4%Media
RHM
€1,037.604.8%-38.1%€48.3b€1,697.8546.030.6%1.1%Capital Goods
WAYS
SEK 40.002.6%0%SEK 350.8mSEK 58.00212.878.5%0%Tech
NVDA
US$206.841.8%17.0%US$5.0tUS$302.8331.422.8%0.5%Semiconductors
SAUD3
R$14.63-3.0%24.6%R$42.8bR$16.6275.743.7%5.6%Healthcare
MX1
AU$0.03-9.1%-53.8%AU$22.4mAU$0.151.3105.5%n/aHealthcare
MOD
US$241.796.1%129.2%US$12.8bUS$340.86105.749.2%n/aCapital Goods
PNI
AU$16.00-7.9%-27.9%AU$3.7bAU$22.1829.820.9%3.5%Diversified Financials
Page 1 of 42
Healthy high growth potential - Investing Ideas - Simply Wall St